Global Blood Pressure Disorders Drug Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-68432 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Blood Pressure Disorders Drug market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: A1M Pharma AB Acceleron Pharma Inc Ache Laboratorios Farmaceuticos SA Actelion Pharmaceuticals Ltd Aerogen Ltd Anavex Life Sciences Corp AnGes Inc Arena Pharmaceuticals Inc Ascendia Pharmaceuticals LLC Ascendis Pharma A/S AVEO Pharmaceuticals Inc Bayer AG Bial - Portela & Ca SA Bioblue Technologies Inc Biogen Inc Biolab Farmaceutica Ltda BioRestorative Therapies Inc Boryung Pharmaceutical Co Ltd Bristol-Myers Squibb Co Camurus AB Capricor Therapeutics Inc Celsion Corp Celtaxsys Inc Chiesi Farmaceutici SpA Chong Kun Dang Pharmaceutical Corp Chugai Pharmaceutical Co Ltd CJ HealthCare Corp Complexa Inc Corion Biotech Srl By Types: Diuretics Angiotensin Converting Enzyme (ACE) Inhibitors Angiotensin Receptor Blockers (ARBs) Others By Applications: Hypertension Hypotension Pulmonary Hypertension Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue 1.5 Market Analysis by Type 1.5.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Diuretics 1.5.3 Angiotensin Converting Enzyme (ACE) Inhibitors 1.5.4 Angiotensin Receptor Blockers (ARBs) 1.5.5 Others 1.6 Market by Application 1.6.1 Global Blood Pressure Disorders Drug Market Share by Application: 2022-2027 1.6.2 Hypertension 1.6.3 Hypotension 1.6.4 Pulmonary Hypertension 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Blood Pressure Disorders Drug Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Blood Pressure Disorders Drug Market Players Profiles 3.1 A1M Pharma AB 3.1.1 A1M Pharma AB Company Profile 3.1.2 A1M Pharma AB Blood Pressure Disorders Drug Product Specification 3.1.3 A1M Pharma AB Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Acceleron Pharma Inc 3.2.1 Acceleron Pharma Inc Company Profile 3.2.2 Acceleron Pharma Inc Blood Pressure Disorders Drug Product Specification 3.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Ache Laboratorios Farmaceuticos SA 3.3.1 Ache Laboratorios Farmaceuticos SA Company Profile 3.3.2 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product Specification 3.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Actelion Pharmaceuticals Ltd 3.4.1 Actelion Pharmaceuticals Ltd Company Profile 3.4.2 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product Specification 3.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Aerogen Ltd 3.5.1 Aerogen Ltd Company Profile 3.5.2 Aerogen Ltd Blood Pressure Disorders Drug Product Specification 3.5.3 Aerogen Ltd Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Anavex Life Sciences Corp 3.6.1 Anavex Life Sciences Corp Company Profile 3.6.2 Anavex Life Sciences Corp Blood Pressure Disorders Drug Product Specification 3.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 AnGes Inc 3.7.1 AnGes Inc Company Profile 3.7.2 AnGes Inc Blood Pressure Disorders Drug Product Specification 3.7.3 AnGes Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Arena Pharmaceuticals Inc 3.8.1 Arena Pharmaceuticals Inc Company Profile 3.8.2 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product Specification 3.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Ascendia Pharmaceuticals LLC 3.9.1 Ascendia Pharmaceuticals LLC Company Profile 3.9.2 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product Specification 3.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Ascendis Pharma A/S 3.10.1 Ascendis Pharma A/S Company Profile 3.10.2 Ascendis Pharma A/S Blood Pressure Disorders Drug Product Specification 3.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 AVEO Pharmaceuticals Inc 3.11.1 AVEO Pharmaceuticals Inc Company Profile 3.11.2 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product Specification 3.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Bayer AG 3.12.1 Bayer AG Company Profile 3.12.2 Bayer AG Blood Pressure Disorders Drug Product Specification 3.12.3 Bayer AG Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Bial - Portela & Ca SA 3.13.1 Bial - Portela & Ca SA Company Profile 3.13.2 Bial - Portela & Ca SA Blood Pressure Disorders Drug Product Specification 3.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Bioblue Technologies Inc 3.14.1 Bioblue Technologies Inc Company Profile 3.14.2 Bioblue Technologies Inc Blood Pressure Disorders Drug Product Specification 3.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Biogen Inc 3.15.1 Biogen Inc Company Profile 3.15.2 Biogen Inc Blood Pressure Disorders Drug Product Specification 3.15.3 Biogen Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Biolab Farmaceutica Ltda 3.16.1 Biolab Farmaceutica Ltda Company Profile 3.16.2 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product Specification 3.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 BioRestorative Therapies Inc 3.17.1 BioRestorative Therapies Inc Company Profile 3.17.2 BioRestorative Therapies Inc Blood Pressure Disorders Drug Product Specification 3.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Boryung Pharmaceutical Co Ltd 3.18.1 Boryung Pharmaceutical Co Ltd Company Profile 3.18.2 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Specification 3.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Bristol-Myers Squibb Co 3.19.1 Bristol-Myers Squibb Co Company Profile 3.19.2 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product Specification 3.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 Camurus AB 3.20.1 Camurus AB Company Profile 3.20.2 Camurus AB Blood Pressure Disorders Drug Product Specification 3.20.3 Camurus AB Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 Capricor Therapeutics Inc 3.21.1 Capricor Therapeutics Inc Company Profile 3.21.2 Capricor Therapeutics Inc Blood Pressure Disorders Drug Product Specification 3.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.22 Celsion Corp 3.22.1 Celsion Corp Company Profile 3.22.2 Celsion Corp Blood Pressure Disorders Drug Product Specification 3.22.3 Celsion Corp Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.23 Celtaxsys Inc 3.23.1 Celtaxsys Inc Company Profile 3.23.2 Celtaxsys Inc Blood Pressure Disorders Drug Product Specification 3.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.24 Chiesi Farmaceutici SpA 3.24.1 Chiesi Farmaceutici SpA Company Profile 3.24.2 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product Specification 3.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.25 Chong Kun Dang Pharmaceutical Corp 3.25.1 Chong Kun Dang Pharmaceutical Corp Company Profile 3.25.2 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product Specification 3.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.26 Chugai Pharmaceutical Co Ltd 3.26.1 Chugai Pharmaceutical Co Ltd Company Profile 3.26.2 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product Specification 3.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.27 CJ HealthCare Corp 3.27.1 CJ HealthCare Corp Company Profile 3.27.2 CJ HealthCare Corp Blood Pressure Disorders Drug Product Specification 3.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.28 Complexa Inc 3.28.1 Complexa Inc Company Profile 3.28.2 Complexa Inc Blood Pressure Disorders Drug Product Specification 3.28.3 Complexa Inc Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.29 Corion Biotech Srl 3.29.1 Corion Biotech Srl Company Profile 3.29.2 Corion Biotech Srl Blood Pressure Disorders Drug Product Specification 3.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Blood Pressure Disorders Drug Market Competition by Market Players 4.1 Global Blood Pressure Disorders Drug Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Blood Pressure Disorders Drug Revenue Market Share by Market Players (2016-2021) 4.3 Global Blood Pressure Disorders Drug Average Price by Market Players (2016-2021) 5 Global Blood Pressure Disorders Drug Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Blood Pressure Disorders Drug Market Size (2016-2021) 5.1.2 Blood Pressure Disorders Drug Key Players in North America (2016-2021) 5.1.3 North America Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.1.4 North America Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Blood Pressure Disorders Drug Market Size (2016-2021) 5.2.2 Blood Pressure Disorders Drug Key Players in East Asia (2016-2021) 5.2.3 East Asia Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.2.4 East Asia Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Blood Pressure Disorders Drug Market Size (2016-2021) 5.3.2 Blood Pressure Disorders Drug Key Players in Europe (2016-2021) 5.3.3 Europe Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.3.4 Europe Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Blood Pressure Disorders Drug Market Size (2016-2021) 5.4.2 Blood Pressure Disorders Drug Key Players in South Asia (2016-2021) 5.4.3 South Asia Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.4.4 South Asia Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Blood Pressure Disorders Drug Market Size (2016-2021) 5.5.2 Blood Pressure Disorders Drug Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.5.4 Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Blood Pressure Disorders Drug Market Size (2016-2021) 5.6.2 Blood Pressure Disorders Drug Key Players in Middle East (2016-2021) 5.6.3 Middle East Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.6.4 Middle East Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Blood Pressure Disorders Drug Market Size (2016-2021) 5.7.2 Blood Pressure Disorders Drug Key Players in Africa (2016-2021) 5.7.3 Africa Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.7.4 Africa Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Blood Pressure Disorders Drug Market Size (2016-2021) 5.8.2 Blood Pressure Disorders Drug Key Players in Oceania (2016-2021) 5.8.3 Oceania Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.8.4 Oceania Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Blood Pressure Disorders Drug Market Size (2016-2021) 5.9.2 Blood Pressure Disorders Drug Key Players in South America (2016-2021) 5.9.3 South America Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.9.4 South America Blood Pressure Disorders Drug Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Blood Pressure Disorders Drug Market Size (2016-2021) 5.10.2 Blood Pressure Disorders Drug Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Blood Pressure Disorders Drug Market Size by Type (2016-2021) 5.10.4 Rest of the World Blood Pressure Disorders Drug Market Size by Application (2016-2021) 6 Global Blood Pressure Disorders Drug Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Blood Pressure Disorders Drug Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Blood Pressure Disorders Drug Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Blood Pressure Disorders Drug Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Blood Pressure Disorders Drug Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Blood Pressure Disorders Drug Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Blood Pressure Disorders Drug Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Blood Pressure Disorders Drug Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Blood Pressure Disorders Drug Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Blood Pressure Disorders Drug Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Blood Pressure Disorders Drug Consumption by Countries 7 Global Blood Pressure Disorders Drug Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Blood Pressure Disorders Drug (2022-2027) 7.2 Global Forecasted Revenue of Blood Pressure Disorders Drug (2022-2027) 7.3 Global Forecasted Price of Blood Pressure Disorders Drug (2022-2027) 7.4 Global Forecasted Production of Blood Pressure Disorders Drug by Region (2022-2027) 7.4.1 North America Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.3 Europe Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.7 Africa Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.9 South America Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Blood Pressure Disorders Drug Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Blood Pressure Disorders Drug by Application (2022-2027) 8 Global Blood Pressure Disorders Drug Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.2 East Asia Market Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.3 Europe Market Forecasted Consumption of Blood Pressure Disorders Drug by Countriy 8.4 South Asia Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.5 Southeast Asia Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.6 Middle East Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.7 Africa Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.8 Oceania Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.9 South America Forecasted Consumption of Blood Pressure Disorders Drug by Country 8.10 Rest of the world Forecasted Consumption of Blood Pressure Disorders Drug by Country 9 Global Blood Pressure Disorders Drug Sales by Type (2016-2027) 9.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2016-2021) 9.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2022-2027) 10 Global Blood Pressure Disorders Drug Consumption by Application (2016-2027) 10.1 Global Blood Pressure Disorders Drug Historic Market Size by Application (2016-2021) 10.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2022-2027) 11 Global Blood Pressure Disorders Drug Manufacturing Cost Analysis 11.1 Blood Pressure Disorders Drug Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Blood Pressure Disorders Drug 12 Global Blood Pressure Disorders Drug Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Blood Pressure Disorders Drug Distributors List 12.3 Blood Pressure Disorders Drug Customers 12.4 Blood Pressure Disorders Drug Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Pharmaceutical Grade Sodium Chloride Market
$2850-$4575
Adenosine Triphosphate ATP Test Kit Market
$3300-$7000
Alpha 1 Antitrypsin Deficiency Treatment Market
$3300-$7000